|
No. |
Date |
Theme |
Slides |
Hand outs
|
Q&A |
Prob lems |
PRS |
Tidbits |
Tests |
Web |
|---|
| 2006 |
2005 |
2004 |
2003 |
|
33
|
M 12-03
|
Personalized Medicine & Pharmacogenomics |
S33
|
H33
|
A33
|
- |
R33 |
FS |
FR |
F06 |
FE |
TO4 |
W33 |
|
32
|
M 12-03
|
Mean Residence Time & Interspecies
Scaling |
S32
|
H32
|
A32
|
P32 |
ET |
- |
T32
|
- |
- |
ST4 |
- |
|
31
|
M 11-26
|
Relation between PK and PD Response
|
S31
|
H31
|
A31
|
P31 |
R31 |
- |
T31 |
T31
|
T31
|
TE4 |
- |
|
30
|
W 11-21
|
Dosage Adjustment in Renal Disease II
|
S30 |
H30
|
A30
|
P30 |
R30 |
T30 |
T30 |
T30 |
T30
|
PT4 |
- |
29 |
M
11-19 |
Dosage Adjustment in Renal Disease I |
S29 |
H29 |
A29
|
P29 |
- |
T29 |
T29 |
T29 |
T29 |
- |
W29 |
28 |
F
11-16 |
Clinical Pharmacokinetics II |
S28 |
H28 |
A28 |
P28 |
R28 |
T28 |
T28 |
T28 |
T28 |
- |
- |
27 |
W
11-14 |
Clinical Pharmacokinetics I |
S27 |
H27 |
A27 |
P27 |
R27 |
T27 |
T27 |
T27 |
T27 |
CP2 |
- |
26 |
F
11-09 |
Multiple-dosage Regimens III |
S26 |
H26 |
A26 |
P26 |
R26 |
T26 |
T26 |
T26 |
T26 |
- |
W26 |
25 |
W
11-07 |
Multiple-dosage Regimens II |
S25 |
H25 |
A25 |
P25 |
R25 |
T25 |
T25 |
T25 |
T25 |
TO3 |
- |
24 |
M
11-05 |
Multiple-dosage Regimens I |
S24 |
H24 |
A24 |
P24 |
R24 |
T24 |
T24 |
T24 |
T24 |
ST3 |
- |
23 |
M 10-29 |
Nonlinear Pharmacokinetics |
S23 |
H23 |
A23 |
P23 |
R23 |
T23 |
T23 |
T23 |
T23 |
TE3 |
W23 |
22 |
F
10-26 |
IV Infusion II |
S22 |
H22 |
A22 |
P22 |
R22 |
T22 |
T22 |
T22 |
T22 |
PT3 |
- |
|
21 |
W
10-24 |
IV Infusion I |
S21 |
H21 |
A21 |
P21 |
R21 |
T21 |
T21 |
T21 |
T21 |
- |
- |
|
20 |
M 10-22 |
Clearance III |
S20 |
H20 |
A20 |
P20 |
R20 |
T20 |
T20 |
T20 |
T20 |
- |
W20 |
19 |
F
10-19 |
Clearance II |
S19 |
H19 |
A19 |
P19 |
R19 |
T19 |
T19 |
T19 |
T19 |
- |
W19 |
18 |
W
10-17 |
Clearance I |
S18 |
H18 |
A18 |
P18 |
R18 |
T18 |
T18 |
T18 |
T18 |
- |
W18 |
17 |
M
10-15 |
Modified-release Dosage Forms II |
S17 |
H17 |
A17 |
P17 |
R17 |
T17 |
T17 |
T17 |
T17 |
- |
W17 |
16 |
F
10-12 |
Modified-release Dosage Forms I |
S16 |
H16 |
A16 |
P16 |
R16 |
T16 |
T16 |
T16 |
- |
- |
W16 |
15 |
W
10-10 |
Bioavailability and Bioequivalence |
S15 |
H15 |
A15 |
P15 |
- |
T15 |
T15 |
T15 |
T15 |
TO2 |
W15 |
14 |
W
10-03 |
Pharmacokinetics of Drug Absorption II |
S14 |
H14 |
A14 |
P14 |
- |
- |
T14 |
T14 |
T14 |
ST2
|
- |
13 |
M
10-01 |
Pharmacokinetics of Drug Absorption I |
S13 |
H13 |
A13 |
P13
|
R13 |
T13 |
T13 |
T13 |
T13 |
TE2 |
- |
|
12
|
F 09-28
|
Physiology of Drug Absorption
|
S12
|
H12
|
A12
|
P12 |
- |
- |
T12
|
T12
|
T12
|
PT2 |
W12 |
|
11
|
W 09-26
|
Distribution and Protein Binding
|
S11
|
H11
|
A11
|
P11
|
R11 |
- |
- |
T11
|
T11
|
- |
W11 |
10 |
M
09-24 |
Multicompartment Models III |
S10 |
H10 |
A10 |
P10 |
R10 |
T10 |
T10 |
T10 |
T10 |
CP1 |
W10 |
9 |
F
09-21 |
Multicompartment Models II |
S9 |
H9 |
A9 |
P9 |
R9 |
T9 |
T9 |
T9 |
T9 |
TO1 |
- |
8 |
M 09-17 |
Multicompartment Models I |
S8 |
H8 |
A8 |
P8 |
R8 |
T8 |
- |
T8 |
T8 |
ST1 |
- |
7 |
M
09-10 |
One-compartment Open Model IV |
S7 |
H7 |
A7 |
P7 |
R7 |
- |
T7 |
T7 |
T7 |
TE1 |
W7 |
6 |
F
09-07 |
One-compartment Open Model III |
S6 |
H6 |
A6 |
P6 |
R6 |
T6 |
T6 |
T6 |
T6 |
PT1 |
- |
5 |
W
09-05 |
One-compartment Open Model II |
S5 |
H5 |
A5 |
P5 |
R5 |
T5
|
T5 |
T5 |
T5 |
- |
- |
4 |
F
08-31 |
One-compartment Open Model I |
S4 |
H4 |
A4 |
P4 |
- |
T4 |
- |
T4
|
T4 |
- |
W4 |
3 |
W
08-29 |
Introduction to Pharmacokinetics |
S3 |
H3 |
A3 |
P3 |
- |
- |
T3 |
T3 |
T3 |
- |
W3 |
2 |
M
08-27 |
Rates and Orders of Reactions |
S2 |
H2 |
A2 |
P2 |
R2 |
- |
- |
T2 |
T2 |
- |
W2 |
1 |
F 08-24 |
Review of Mathematical Fundamentals |
S1 |
H1
|
A1 |
P1 |
- |
- |
- |
T1 |
T1
|
- |
W1 |
0 |
W 08-22 |
Orientation |
S0
|
H0 |
- |
- |
- |
- |
- |
- |
- |
SS |
- |